PHARMACOKINETIC BASIS OF INTRAVENOUS DRUG DELIVERY

被引:5
|
作者
GLASS, PSA
DOHERTY, D
JACOBS, JR
QUILL, TJ
机构
来源
BAILLIERES CLINICAL ANAESTHESIOLOGY | 1991年 / 5卷 / 03期
关键词
D O I
10.1016/S0950-3501(05)80050-9
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We have seen in recent years the release of numerous intravenous anaesthetic agents whose duration of action is relatively short, thus lending themselves to administration via continuous infusion. Clinical studies have clearly demonstrated the advantages of continuous infusion over repeated bolus dosing. These two factors have prompted pump manufacturers to produce devices that simplify the administration of intravenous anaesthetics by continuous infusion. It is concentration rather than dose that results in the desired effect. Utilizing pharmacokinetic principles, it is possible to provide automated drug delivery systems whereby the device can produce a clinician-specified drug concentration. In addition, where there is an easily measurable end-point, closed-loop feedback control can be implemented automatically to control the desired parameter within a very narrow range. With this rapid development in intravenous drug delivery, it becomes imperative that clinicians familiarize themselves with these new drug delivery devices so that they can use them optimally to care for their patients. © 1991 Baillière Tindall.
引用
收藏
页码:735 / 775
页数:41
相关论文
共 50 条
  • [41] INFLUENCE OF SPECIFIC-GRAVITY ON INTRAVENOUS DRUG DELIVERY
    RAJCHGOT, P
    RADDE, IC
    MACLEOD, SM
    JOURNAL OF PEDIATRICS, 1981, 99 (04): : 658 - 661
  • [42] Solid lipid nanoparticles (SLN) for intravenous drug delivery
    Muller, RH
    zurMuhlen, A
    Freitas, C
    Mehnert, W
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 184 - 185
  • [43] INFLUENCE OF PHYSICAL CHARACTERISTICS OF INTRAVENOUS SYSTEMS ON DRUG DELIVERY
    KUBAJAK, CAM
    LEFF, RD
    ROBERTS, RJ
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1988, 11 (04): : 189 - 195
  • [44] QUALITY ASSURANCE AUDIT OF AN INTRAVENOUS DRUG DELIVERY SYSTEM
    HAGEL, HP
    LENZE, CJ
    OLSON, PA
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (06): : 1359 - 1360
  • [45] Guaranteeing drug delivery during total intravenous anaesthesia
    Craft, T. M.
    ANAESTHESIA, 2015, 70 (06) : 758 - 759
  • [46] Guaranteeing drug delivery in total intravenous anaesthesia Reply
    Hartle, A.
    ANAESTHESIA, 2015, 70 (03) : 362 - 362
  • [47] INTRAVENOUS DRUG DELIVERY CONSIDERATIONS FOR NEWBORN-INFANTS
    WEATHERSTONE, KB
    LEFF, RD
    SEMINARS IN PERINATOLOGY, 1992, 16 (01) : 41 - 46
  • [48] Why Collecting Pharmacokinetic Information After Intravenous Drug Administration Is Important
    Hinderling, Peter H.
    Papoian, Thomas
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (02): : 146 - 150
  • [49] PHARMACOKINETIC EVALUATION OF SITE-SPECIFIC DRUG DELIVERY SYSTEMS
    AARONS, L
    BODDY, A
    PETRAK, K
    NOVEL DRUG DELIVERY AND ITS THERAPEUTIC APPLICATION, 1989, : 121 - 126
  • [50] Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
    Varela-Fernandez, Ruben
    Diaz-Tome, Victoria
    Luaces-Rodriguez, Andrea
    Conde-Penedo, Andrea
    Garcia-Otero, Xurxo
    Luzardo-Alvarez, Asteria
    Fernandez-Ferreiro, Anxo
    Otero-Espinar, Francisco J.
    PHARMACEUTICS, 2020, 12 (03)